Skip to content

Investigating the effect of performing the first stage of periodontal treatment on the pulmonary function of patients with rheumatoid arthritis

Investigating the effect of performing the first stage of periodontal treatment on the pulmonary function of patients with rheumatoid arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230615058492N3
Enrollment
56
Registered
2025-07-22
Start date
2025-09-04
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Periodontitis. Condition 2: Rheumatoid arthritis. Gingivitis and periodontal diseases Other rheumatoid arthritis

Interventions

Intervention 1: Intervention group: The first phase of periodontal treatment includes hygiene education such as the correct way to brush your teeth (using the Modified Bass method) and supra- and subg

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Confirmed RA Having at least 10 teeth No definitive diagnosis of COPD (patients without airway obstruction with FEV1/FVC = 0.7) Having periodontitis stage II-IV and grade B

Exclusion criteria

Exclusion criteria: fever history of adult-onset or infectious diseases history of lung-reducing surgeries history of lung transplantation or pneumonectomy history of any periodontal treatment in the last 6 months or antibiotic use in the last 3 months smoking history of any inflammatory disease except RA and periodontitis history of diabetes pregnancy or breastfeeding

Design outcomes

Primary

MeasureTime frame
Forced Expiratory Volume in one second/ Forced Vital Capacity (FEV1/FVC). Timepoint: Before intervention, three months after intervention, six months after intervention. Method of measurement: Spirometry test.

Secondary

MeasureTime frame
Erythrocyte Sedimentation Rate(ESR). Timepoint: Before intervention, three months after intervention, six months after intervention. Method of measurement: Blood test.;C_reactive protein (CRP). Timepoint: Before intervention, three months after intervention, six months after intervention. Method of measurement: Blood test.;Creactive protein/Albumin (CRP/ALB). Timepoint: Before intervention, three months after intervention, six months after intervention. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPegah Katiraie

Yazd University of Medical Sciences

Pegahkatiraie1376@gmail.com+98 35 3625 5881

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026